Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Enzyme Inhibition Assay from US Patent US8609710: "Cycloalkyl-substituted imidazole derivative"
Assay data:27 Active, 29 Activity ≤ 1 µM, 29 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Inhibition Assay from Article 10.1111/j.1747-0285.2008.00752.x: "Aromatic organic compounds as scaffolds for metallocarboxypeptidase inhibitor design."
Assay data:4 Active, 1 Activity ≤ 1 µM, 11 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Enzyme Inhibitory Assay from US Patent US9662310: "Cyclopropanecarboxylic acid derivative"
Assay data:59 Active, 63 Activity ≤ 1 µM, 66 Tested
TAFI Activity Assay from US Patent US9688645: "Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa"
Assay data:25 Active, 24 Activity ≤ 1 µM, 25 Tested
Ex vivo inhibition of TAFI in Sprague-Dawley rat blood TAFI at 0.6 mg/kg, iv measured after 60 mins by thromboelastometry analysis relative to control
Assay data:13 Tested
SummaryPubMed CitationRelated BioAssays by Target
Ex vivo inhibition of TAFI in Sprague-Dawley rat blood TAFI at 0.6 mg/kg, iv measured after 30 mins by thromboelastometry analysis relative to control
Assay data:11 Tested
Inhibition of TAFI in Sprague-Dawley rat blood TAFI incubated for 2 mins using hippuryl-arginine as substrate by thromboelastometry analysis
Assay data:2 Active, 2 Activity ≤ 1 µM, 2 Tested
Inhibition of TAFI in Sprague-Dawley rat blood TAFI at 0.8 uM incubated for 2 mins using hippuryl-arginine as substrate by thromboelastometry analysis relative to control
Assay data:14 Tested
Inhibition of recombinant human activated TAFI at 10 uM incubated for 45 mins using hippuryl-arginine as substrate by spectrophotometry relative to control
Assay data:8 Tested
Inhibition of recombinant human activated TAFI incubated for 45 mins using hippuryl-arginine as substrate by spectrophotometry
Assay data:39 Active, 2 Activity ≤ 1 nM, 27 Activity ≤ 1 µM, 55 Tested
Inhibition of TAFIalpha in human plasma incubated for 15 mins by chromogenic assay
Assay data:4 Active, 4 Activity ≤ 1 µM, 4 Tested
Inhibition of human TAFI at 1 nM to 1 mM using AAFA as substrate preincubated for 45 mins measured at 30 sec intervals for 15 mins by UV/vis-spectrophotometry
Assay data:1 Tested
Inhibition of human plasma activated thrombin-activatable fibrinolysis inhibitor after 10 mins in absence of DTT
Inhibition of human plasma activated thrombin-activatable fibrinolysis inhibitor after 10 mins in presence of DTT
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Human Carboxypeptidase B2 (plasma) (M14: Carboxypeptidase A)
Assay data:4 Active, 4 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Inhibition of activated TAFI in human blood by clot lysis assay
Inhibition of activated human plasma TAFI incubated for 15 mins in presence of 1% human serum albumin by chromogenic assay
Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assay
Assay data:37 Active, 21 Activity ≤ 1 µM, 51 Tested
Inhibition of human activated TAFI incubated for 15 mins in presence of 1% human serum albumin by microtiter plate reader based assay
Inhibition of human activated TAFI incubated for 15 mins by microtiter plate reader based assay
Assay data:40 Active, 1 Activity ≤ 1 nM, 35 Activity ≤ 1 µM, 42 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on